methyl aminolevulinate
Selected indexed studies
- Topical methyl aminolevulinate. (Am J Clin Dermatol, 2004) [PMID:15109276]
- Methyl aminolevulinate: actinic keratoses and Bowen's disease. (Dermatol Clin, 2007) [PMID:17126745]
- Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis. (Photodiagnosis Photodyn Ther, 2020) [PMID:31978564]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Topical methyl aminolevulinate. (2004) pubmed
- Methyl aminolevulinate: actinic keratoses and Bowen's disease. (2007) pubmed
- Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis. (2020) pubmed
- Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. (2009) pubmed
- Segmental porokeratosis responding to methyl aminolevulinate photodynamic therapy. (2020) pubmed
- Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. (2007) pubmed
- Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl Aminolevulinate. (2025) pubmed
- Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions. (2019) pubmed
- Allergic contact dermatitis caused by methyl aminolevulinate. (2013) pubmed
- Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy. (2020) pubmed